Early mammalian development entails a series of cell fate transitions that includes transit through naïve pluripotency to post-implantation epiblast. This subsequently gives rise to primordial germ cells (PGC), the founding population of the germline lineage. To investigate the gene regulatory networks that control these critical cell fate decisions, we developed a compound-reporter system to track cellular identity in a model of PGC specification (PGC-like cells; PGCLC), and coupled it with unbiased genome-wide CRISPR screening. This enabled identification of key genes both for exit from pluripotency and for acquisition of PGC fate, with further characterisation revealing a central role for the transcription factors Nr5a2 and Zfp296 in germline ontogeny. Abrogation of these genes results in significantly impaired PGCLC development due to widespread activation (Nr5a2 -/-) or inhibition (Zfp296 -/-) of WNT pathway components. This leads to aberrant upregulation of the somatic programme or failure to appropriately activate germline genes in PGCLC, respectively, and consequently loss of germ cell identity. Overall our study places Zfp296 and Nr5a2 as key components of an expanded PGC gene regulatory network, and outlines a transferable strategy for identifying critical regulators of complex cell fate transitions. 6 7.25, which arise from 'competent' epiblast precursor cells in response to BMP and WNT 7 signalling 1,2 . The specification of PGCs is accompanied by induction of key germ-cell genes, 8
The germ cell lineage generates the totipotent state and transmits heritable genetic and epigenetic 3 information to the next generation. Robust specification of primordial germ cells (PGC), the 4 precursors of sperm and eggs, is therefore a critical developmental event to ensure the propagation of 5 a species. Approximately thirty specified PGCs are detected in mouse embryos at embryonic day (E) 89 Following introduction of the CRISPR library, we identified 627 genes that lead to a loss of naïve 90 ESC maintained in 2i/LIF when knocked-out (p<0.01 in both replicates) (Fig 2A) . Gene ontology 91 (GO) terms for these genes were highly enriched for fundamental biological processes such as 92 ribosome biogenesis (p=2.8 x 10 -27 ; e.g. Rps5) and protein translation (p= 4.2 x 10 -30 ; e.g. Eif6), 93 supporting the efficacy of the library (Fig S2A) . Notably ESC carrying mutations for the core 94 pluripotency factors Oct4 and Sox2 were also highly depleted, consistent with their essential role in 95
propagating pluripotent ESC 18 (Fig 2A, B; S2C ). The majority of naïve pluripotency genes were not 96 depleted however, which is in line with the capacity of 2i/LIF media to buffer against a single genetic 97 perturbation to the naïve pluripotency network ( Fig 2B) 19 . Importantly, this enables the role of such 98 naïve pluripotency genes to be examined in PGC specification, since knockout cells remain in the 99 population. Exceptions however are Nanog and Tfcp2l1, which are likely depleted owing to a 100 proliferation disadvantage upon knockout in ESC. In contrast to the many depleted genes, we 101 observed that only twenty-one genes become enriched in the population upon knockout, primarily 102 corresponding to tumour-suppressors ( Fig S2B & C) . Amongst these Trp53 (p53) is the top hit, 103
suggesting that p53-mutant mouse ESC acquire a major selective advantage, similarly to recent 104 reports in human ESC 20 . 105 106 We next compared the genes essential for naïve ESC (in 2i/LIF) with those essential for ESC in 107 conventional serum/LIF culture, which represents an alternative pluripotent state 18 . Using datasets 108 from the same CRISPR library 17 , we observed good overlap (62%) between ESC conditions, but 109 noted 38% of genes appear to be critical under only specific pluripotent culture parameters ( Fig 2C) . 110 Among the 2i/LIF specific genes were Ogdh and Dlst; two enzymes that mediate a-ketoglutarate 111 metabolism which feeds into the TCA cycle. We used siRNAs to test acute loss of Ogdh and observed 112 a significant reduction of proliferation and/or increased cell death in 2i/LIF ESC but not serum/LIF 113 ESC ( Fig 2D) . We also tested Txn1, which was scored as essential in both pluripotent ESC states, and 114
found an equivalent cell reduction in 2i/LIF and serum/LIF ( Fig 2D) . These data suggest ESC in 115 distinct pluripotent states rely, in part, on distinct genetic networks, with ESC in 2i/L uniquely reliant 116
on Ogdh metabolism of a-ketoglutarate for example. More generally, establishing this mutant SGET 117 ESC population enables screening for functional regulators of EpiLCs, and subsequently PGCLCs, 118 without confounding general survival genes. 119 120
Acquisition of post-implantation epiblast fate 121 We next used fluorescence-activated flow sorting (FACS) to isolate EpiLC that successfully transited 122 to the SG -ET + epiblast state, as well as cells that maintained Stella expression (SG + ET + ) (<2%), 123
indicative of failure to exit naïve pluripotency. Analysis of this SG + ET + EpiLC population revealed 124 enrichment for 21 candidate genes with potential intrinsic roles in dissolution of naïve pluripotency 125 (p<0.01), including the two prototypical regulators Tcf3 and Zfp281 (Fig 2E & S3A) 21, 22 . The 126
candidates additionally included the epigenetic regulator Dnmt1 and also Rest, which are known to 127 be important during early differentiation 23, 24 . 128 129
To test the role of novel candidates in driving exit from pluripotency we generated ESC knockouts 130
for Zmym2 (also known as Zfp198), FoxP1, Uchl5, and Zfp281 as a positive control, using CRISPR 131
targeting. Consistent with their failure to repress Stella-GFP during EpiLC formation, mutant EpiLC 132 were also impaired in activation of key epiblast markers Fgf5, Dnmt3b and Otx2, whilst their 133 proliferation appeared unaffected ( Fig 2F & S3B-C) . We observed both a delay in activation of 134 epiblast genes and a reduction in their absolute levels in knockout lines, despite high levels of 135 powerful differentiation-inducing FGF and ACTIVIN in the culture medium. Notably, the Zmym2-, 136
FoxP1-, Uchl5-mutant lines exhibited expression defects comparable with the bona fide exit from 137 pluripotency regulator Zfp281, supporting an important role for them in the timely acquisition of post-138 implantation cell identity. Consistently all three candidates are transcriptionally upregulated during 139
EpiLC induction ( Fig S3D) . 140 141
Candidate genes for specification of PGC fate 142 We next focused on genes involved in mouse germline specification by inducing PGCLC from 143 competent SG -ET + EpiLC. In order to obtain sufficient numbers of PGCLCs for coverage of the 144 gRNA library, we optimised and scaled-up the induction ( Fig S4A) . Specified SG + ET low PGCLC 145
were FACS purified at d6 to allow time for depletion of cells carrying mutations in critical germline 146 genes. Because PGCLC numbers remained a limiting factor however, we relaxed the candidate 147 threshold to p<0.05, whilst retaining a p<0.01 in at least one replicate, to account for increased noise 148 ( Fig S4B) . This resulted in identification of 23 candidate genes involved in specification and/or 149 development of nascent PGC. The frequency of gRNAs targeting these genes was highly depleted in 150 PGCLC relative to preceding EpiLC ( Fig 3A) , whilst control gene families were not depleted ( Fig  151  S4C ). Moreover, genes with an established critical role in PGC specification, such as Blimp1, 152
Cbfat2t2 and Prdm14, also showed marked reduction in gRNA frequency in PGCLC, supporting the 153 efficacy of the screen ( Fig 3A) . These genes narrowly failed to meet significance across all replicates 154 however; Cbfa2t2 scored p-values of p=0.00006 and p=0.22 for example. We also noted that several 155 pluripotency genes (Nr5a2, Esrrb and Sall4) were depleted specifically from PGCLC ( Fig S4C) , 156
suggesting several genes typically linked with pluripotency have a potentially important function in 157 the germline. 158 159
To refine our candidate list we examined their expression profile during induction of PGCLC from 160 the transduced SGET ESC by RNA-seq. This confirmed that SG + ET low PGCLC activate high levels 161
of key PGC markers such as Blimp1, Stella, Itgb3, Nanos3 and Prdm14, supporting their authentic 162 germline identity ( Fig S4D) . The dynamics of candidate gene expression revealed four broad clusters, 163
with cluster 1 and 4 corresponding to genes that are expressed relatively stably throughout ESC to 164 PGCLC transition, with the latter nonetheless only just above the detection threshold implying it may 165 filter out false-positives. In contrast, cluster 2 and 3 reflected dynamically regulated genes that are 166 activated in PGCLC, with cluster 3 corresponding to genes fully silenced in EpiLC before strong 167 reactivation, and including known PGC specifiers ( Fig 3B) . From these, we chose to focus on Zfp296 168
and Nr5a2, since they rank 3 and 7 overall in the screen, and exhibit comparable PGCLC expression 169 dynamics to Prdm14 and Blimp1 (Fig 3B & S4D) . Nr5a2 encodes an orphan nuclear receptor 170 previously associated with reprogramming towards pluripotency, and also has a role in 171 extraembryonic development, which leads to embryonic lethality when abrogated 25 . Zfp296 encodes 172 a zinc-finger protein that was amongst the original twenty Yamanaka factors, and has recently been 173
shown to influence heterochromatin and iPS generation 26-28 . 174 175
Inspection of the individual gRNAs that target Nr5a2 and Zfp296 revealed a strong and reproducible 176 reduction of their frequency specifically in PGCLC, but not in the preceding developmental 177 transitions ( Fig 3C) . Moreover, single-cell RNA-seq indicates both genes are highly upregulated in 178 nascent PGC in vivo at the very onset of specification, but not in adjacent somatic cells ( Fig 3D) . 179 Both Nr5a2 and Zfp296 are also strongly upregulated in early human PGCs ( Fig S4E) , and fail to be 180 activated in Blimp1 -/-PGC that are destined to diverge from the germline lineage ( Fig 3D) . The 181 striking upregulation of these genes during incipient PGC specification, coupled with their high rank 182
in the functional screen, prompted us to investigate their role in detail. 183 184
Nr5a2 and Zfp296 regulate germline ontogeny 185 We used CRISPR editing to generate frameshifted null-alleles of Nr5a2 or Zfp296 in SGET ESC. 186
Nr5a2 -/-ESC proliferated normally, expressed comparable levels of naïve pluripotency genes, and 187 exhibited indistinguishable morphology from parental and matched WT ESC derived from the same 188 targeting process. However upon induction of PGCLC, we observed a marked reduction in 189 specification efficiency of Nr5a2 -/cells at day 2 (d2) relative to WT controls (WT 19.8% ± 8.9; KO 190 6.4% ± 2.3) ( Fig 4A) . Despite the dramatic reduction in numbers, both mutant-lines give rise to some putative PGCLC. To 203 examine the identity of these cells, and their developmental trajectory, we performed RNA-seq. 204
Unbiased hierarchical clustering revealed that Nr5a2 -/-EpiLC were interspersed with WT, but that 205 PGCLC were clustered according to genotype, implying transcriptional differences in the absence of 206
Nr5a2 primarily arise upon induction of germline fate ( Fig S5) . To investigate this further we used 207 principal component analysis (PCA), which confirmed that mutant EpiLC cluster closely with WT 208 but that Nr5a2-null PGCLC progressively diverge from WT controls during their development ( Fig  209  4C ). By day 6 a strong distinction is apparent. This is consistent with Nr5a2 -/-EpiLC being competent 210 for the germline lineage but undergoing an abnormal developmental trajectory upon PGCLC 211 specification, which coincides with the timing of Nr5a2 upregulation in WT cells. 212 213
Global transcriptome clustering of Zfp296-null cells indicated that precursor EpiLC were distinct yet 214 highly comparable between WT and knockout lines ( Fig S5) . Indeed, PCA showed Zfp296 -/-EpiLC 215 cluster closely with WT. In contrast, d2 mutant PGCLC exhibited a significantly different state from 216
WT counterparts, that is closer to precursor EpiLC and thus apparently impaired in its developmental 217 path towards germline fate, which is consistent with the subsequent loss of PGCLC numbers ( Fig  218  4D ). The remaining Zfp296-mutant PGCLC at day 6 appeared to partially re-establish the expected 219 global profile, albeit with greater transcriptome variance between lines than WT. This implies that 220 despite widespread transcriptional mis-regulation, a minor proportion of mutant PGCLC can 221 overcome the effects of Zfp296 abrogation, and potentially give rise to putative germ cells ( Fig 4D) . 222
Overall, these data suggest that loss of Nr5a2 or Zfp296 has a dramatic influence on PGC 223 development.
225 Nr5a2 and Zfp296 converge on reciprocal regulation of WNT 226
To investigate the mechanisms that impairs development of mutant PGCLC and underpin their 227 aberrant transcriptomes in more depth, we identified differentially expressed genes (adjusted p<0.05; 228 >2 FC) in EpiLC and PGCLC. This revealed that downregulation of naïve pluripotency genes and 229 upregulation of postimplantation markers proceeded similarly between Nr5a2 -/and WT EpiLC 230 counterparts ( Fig 5A) . Moreover, there was appropriate upregulation of early PGC markers such as 231
Nanos3, Stella, Blimp1 and Prdm14 in d2 Nr5a2 -/-PGCLC, that was at least equivalent to WT, albeit 232 with a modest failure to upregulate Nanog. However, we noted d2 Nr5a2-null PGCLC exhibited a 233 highly significant over-expression of WNT pathway genes and targets, including Cdx2, T and Mixl1 234 ( Fig 5A) . This was further reflected in gene ontology (GO) analysis of differentially expressed genes 235 at d2, which highlighted Canonical WNT signalling pathway (adjusted p=0.0061) and Pattern 236 specification process (adjusted p=0.014). We confirmed hyperactivation of key WNT pathway genes 237
T and Wnt3 in early Nr5a2-/-PGCLC using qRT-PCR on independent replicates ( Fig 5B) . Strong 238 over-expression of the master mesoderm regulator T is predicted to override its role in germ cell 239 induction and divert cells toward a somatic mesendoderm programme. Indeed, consistent with this, 240
the surviving Nr5a2 -/-PGCLC at day 6 exhibit acute activation of mesendoderm regulators such as 241
Tbx4, Hey1 and Pou2f3 ( Fig 5A) . This collectively suggests that the absence of Nr5a2 leads to 242 aberrant transduction of WNT signalling in nascent PGCLC, which in turn leads to upregulation of 243 mesendoderm master-regulators and consequently de-repression of a somatic programme. It is 244 possible that the aberrant activation of somatic genes in the absence of Nr5a2 is a contributing factor 245 that drives the majority of prospective PGCLC out of the germline programme, leading to reduced 246 efficiency of specification. 247 248
We next analysed gene expression in Zfp296-null EpiLC, which revealed that pluripotency genes 249
including Nanog, Esrrb and Tfcp2l1 were repressed as expected, whilst EpiLC markers such as Fgf5 250
and Dnmt3b were appropriately upregulated. In contrast mutant PGCLC at day 2 exhibited a clear 251 signature of mis-expressed genes ( Fig 5A) . Remarkably, GO analysis again suggested this primarily 252 corresponded to WNT targets, but in in contrast to hyperactivation of WNT in Nr5a2 -/-PGCLC, 253
Zfp296-null PGCLC exhibited a severe block of WNT-associated gene activation; the top enrichment 254
is Negative regulation of canonical WNT signalling (adjusted p=0.0064). Amongst all genes T is the 255 most significantly downregulated in early Zfp296-mutant PGCLC, with Cdx2, Notum and Dkk1 also 256 being amongst the top 20. The absence of appropriate level WNT signalling could manifest as 257 impaired activation of critical germline genes that are WNT and/or T targets 5 . Indeed, Zfp296-null 258 PGCLC at d2 exhibited a block in Blimp1, Prdm14 Cbfa2t2a and Ap2γ activation ( Fig 5A) . qRT-259 PCR analysis independently confirmed highly impaired T and WNT genes in Zfp296-mutant PGCLC 260 and concomitant significant reduced activation of germline regulators Blimp1 and Ap2γ (Fig 5B) . 261
This suggests that absence of Zfp296 establishes a reciprocal developmental failure relative to 262 deletion of Nr5a2, with both genes converging on regulation of appropriate WNT signalling in 263 nascent PGCLC. In the case of Zfp296, this appears to manifest in a delayed but dramatic loss of 264 PGCLC by d6. Notably, the SG -ETcells from both Nr5a2 and Zfp296 embryoids, which have 265 putatively acquired somatic fate, exhibited comparable expression of lineage-specific markers Sox17, 266
Hoxa1 and Sox7 relative to wild-type ( Fig S6A) . This implies that the loss of function for both genes 267 does not impede the exit from the pluripotent state towards somatic fates, but these cells are impaired 268 specifically in their capacity to form PGCs. 269 270
Rescue of Nr5a2 and Zfp296 deficiency 271 We considered that the impaired specification and aberrant transcriptome of mutant PGCs could be 272 due to impaired epigenetic reprogramming, as reported in Prdm14 -/-PGC 10 . To investigate this, we 273 quantified global DNA methylation erasure and observed that WT, Nr5a2 -/-, and Zfp296 -/-PGCLC all 274 underwent extensive and comparable DNA demethylation ( Fig 6A) . This was confirmed by bisulfite 275 pyrosequencing analysis of LINE-1 elements ( Fig S6B) . We therefore turned our attention back to 276 understanding whether the observed mis-regulation of WNT could be driving impaired germline fate, 277
by exposing incipient PGCLC to WNT inhibitor (WNTin: XAV939) or WNT agonist (WNTag: 278
Chiron). Addition of WNTin led to strong downregulation of key PGC genes including T and Wnt3, 279
as well as Nanog, consistent with the effects of impaired WNT transduction in Zfp296-null PGCLC 280
( Fig 6B) . Reciprocally, WNTag affected an increase in expression of T and Wnt3 at d2, whilst also 281
downregulating Nanog, which is in line with the effects of WNT over-activity in Nr5a2-null PGCLC. 282
Indeed, WNTag also elicited overexpression of mesendoderm gene Hey1 by d6 PGCLC (Fig 6C) . 283
Notably WNTinh led to a significant depletion of specified PGCLC (p<0.05), whilst partial WNT 284 activation by WNTag also trended towards impaired PGCLC specification ( Fig 6D) . These data 285
suggest that precise levels of WNT activity are necessary for optimal PGC specification. 286 287
Addition of WNTin to Nr5a2 -/-PGCLC rescued hyperactivated T and Wnt3, demonstrating that their 288 upregulation in Nr5a2-mutant PGCLC is likely a direct consequence of de-regulated WNT activity 289 ( Fig 6B) . In contrast addition of excess WNTag to Zfp296-mutant PGCLC only resulted in modest 290 rescue of aberrantly repressed WNT targets, suggesting that in the absence of Zfp296, germ cells 291 cannot respond to WNT activation, even when forced. We therefore attempted to rescue the 292 specification defects by generating mutant PGCLC that carry Doxycycline(DOX)-inducible 293 expression of wild-type Nr5a2 and Zfp296. We induced Nr5a2 expression specifically during PGCLC 294 induction in a Nr5a2 -/background, which led to a highly significant rescue of PGCLC specification. 295
Moreover, this reimposed supression of somatic and WNT target genes, implying a direct effect of 296
Nr5a2 on these pathways ( Fig 6E & S6C-D) . In contrast, we found expression of Zfp296 to be highly 297 toxic to both ESC and PGCLC, even at very low background (leaky) levels, suggesting precise control 298 over its expression level is important. 299 300
Remarkably DOX-induced Nr5a2 expression in mutant PGCLC resulted in increased PGCLC 301
induction as compared to wild-type counterparts. This encouraged us to test whether Nr5a2 could 302 drive germ line fate independently of BMP cytokines that are normally requisite. Here, forced 303 expression of Nr5a2 in wild-type EpiLC led to emergence of SG + ET low PGCLC at >10-fold higher 304 efficiency than background; at levels comparable with forced expression of canonical PGC-specifier 305
Prdm14, albeit at low absolute frequency (3.3%) ( Fig 6F) . Induction of Nr5a2 resulted in PGCLC 306
with apparently similar expression profiles as authentic PGCs ( Fig S6E) . This indicates that activation 307
of Nr5a2 can, at low efficiency, directly induce PGC-like fate from competent EpiLC. More 308 generally, our data places Nr5a2 and Zfp296 as critical regulators that provide robustness to germline 309 specification by modulating appropriate WNT activity. 310 311 312
DISCUSSION

313
Our study outlines a principle for using CRISPR screens to deconvolve the genetic basis of complex 314 cell fate decisions. By establishing a 'traffic-light' SGET reporter system we traced the pathway from 315 pluripotency to germ cell fate, and identified important genes for each transition. This strategy can 316 be transposed to interrogate multi-step transitions towards any lineage for which a faithful compound-317 reporter or isolation method can be developed. 318 319
Utilising SGET we identified genes involved in exiting naïve pluripotency, including the previously 320
described key regulators Zfp281 and Tcf3 29,30 , and further validated roles for novel candidates Zmym2, 321
FoxP1 and Uchl5. Amongst these Zmym2 expression is anti-correlated with naïve pluripotency genes 322 in heterogeneous single-ESC 31 , and is upregulated when cells are induced to egress from naïve 323 pluripotency both in vitro and in vivo ( Fig S3) . Indeed, ZMYM2 is known to directly interact with 324 NANOG 32 , and its negative regulatory activity could potentially blunt NANOG function thereby 325
promoting exit from pluripotency, or it could alternatively function in this role as part of the LSD1 326 complex 33 . Interestingly the transcription regulator FoxP1 is also strongly activated during EpiLC 327
induction and, whilst it can be alternatively spliced to generate a pro-pluripotency isoform 34 , our data 328 implies canonical Foxp1 isoforms play a role in antagonising naïve pluripotency. The potential 329 mechanism of function for the deubiquitinase Uchl5 is less clear, but it has previously been associated 330
with regulation of the TGF-β/Smad pathway 35 . Future work will be important to characterise the 331 regulatory role of the full repertoire of candidates in control of pluripotent status. 332 333 We further exploited the SGET strategy to identify Zfp296 and Nr5a2 as key functional genes for the 334 germline lineage and as important parts of an expanded PGC gene regulatory network. Deletion of 335
either Nr5a2 or Zfp296 converges on mis-regulation of the WNT pathway, resulting in its aberrant 336 activation or inhibition respectively, implying that precisely regulated levels of WNT is fundamental 337
for germ cell ontogeny. Indeed, loss of either gene leads to severely disrupted PGCLC development.
338
Of note Nr5a2 is a reported WNT target 36 and directly interacts with β-catenin 37 , raising the 339 possibility it forms a negative-feedback loop with WNT to modulate appropriate signalling levels in 340
PGCs. This must strike a balance between WNT-mediated activation of germ cell regulators such 341
Blimp1 and Prdm14 5 , and the capacity to subsequently repress the WNT co-activated mesodermal 342 programme. By blunting WNT activity, NR5A2 may ensure the threshold is tipped towards 343 reversibility, since in its absence PGCLC development is impaired and linked with aberrant activation 344 of mesendodermal genes. Functionally, Nr5a2 was previously shown to be important for 345
reprogramming somatic cells to iPS cells but not for pluripotency per se [38] [39] [40] added to the outer 36 wells. After 2-6 days, EBs were collected for fluorescence-activated cell sorting 420 (FACS) or gene expression analyses. SGET EpiLCs were also seeded in GK15 medium without 421 cytokines as a negative control to normalise for background levels of SGET fluorescence in 422 embryoids. Where indicated, WNT inhibitor XAV939 (10 µM) or agonists CHIR99021 (3µM) were 423 added upon induction of PGCLC in embryoids. Where indicated doxycycline was added at 200 ng/ul 424 upon induction of PGCLC in embryoids +/-above mentioned cytokines. 425 426
Generation and validation of the SGET reporter 427
Embryonic stem cell lines carrying Stella-GFP BAC (SG) 45 were derived as previously described, 428
and routinely checked for mycoplasma-negative status using the mycoalert detection kit (Lonza). 429
These lines were used as the substrate to target an in-frame tdTomato cassette into exon 1 of Esg1 and colonies were picked and screened for correct targeting by PCR. We tested for faithful reporter 439 activity using tetraploid embryo complementation (~E8.5) and chimera formation assays (E12.5). For 440 tetraploid complementation assay, 2-cell stage diploid embryos were collected in M2 medium from 441 the oviduct of mice at E1.5, and washed 3 times with medium containing 0.01% polyvinyl alcohol 442 (Sigma), 280 mM Mannitol (Sigma), 0.5 mM Hepes (Sigma), and 0.15 mM MgSO4 (Sigma). 443
Electrofusion of blastomeres to produce tetraploid embryos was subsequently carried out using a DC 444 pulse (100 V/mm, 30 msec, 1 time) followed by application of AC pulses (5 V/mm, 10 sec) using 445 ECM 200 (BTX, Holliston, MA). Tetraploid embryos were transferred into KSOM medium (Merck 446 Millipore) and cultured for 24 hours for 4-cell / morula injection. For chimera formation assay, 447 morula stage diploid embryos were collected in M2 medium from the oviduct of mice at E2.5. For 448 micro-manipulation, a piezo-driven micro-manipulator (Prime Tech, Tokyo, Japan) was used to drill 449 through the zona pellucida and 5-10 SGET ESCs were introduced into the perivitelline space of 450 morula stage tetraploid or diploid embryos. They were cultured to the blastocyst stage and then 451 transferred into the uteri of pseudopregnant recipient MF1 female mice (E2.5). Post-implantation 452 embryos were dissected at ~E4.5, E6.0, E7.0, E8.5 and E12.5 to analyse eGFP and tdTomato 453 expression. 454 455
Lentiviral CRISPR screen 456
A genome-wide lentiviral CRISPR gRNA library was utilised that contains 87,897 gRNAs targeting 457 19,150 mouse protein-coding genes (Yusa et al), with up to 5 gRNAs per gene (Addgene: #50947). 458
The gRNA library was amplified with NEB 10-beta electrocompetent E.coli (NEB) as per the 459 recommended protocol. Briefly, E.coli were transformed via high efficiency electroporation, to 460 ensure faithful library replication, and incubated at 37°C for 1 hour with SOC recovery medium 461 (ThermoFisher) before growing in 500ml 2xTY (16 g/L Tryptone, 10 g/L Yeast Extract, 5.0 g/L 462 NaCl) + ampicillin (50 µg/ml) mediums at 37°C overnight with 230 rpm shaking. Plasmid was 463 purified from 500 ml bacterial cultures using an endotoxin-free plasmid maxi kit (Qiagen) as per 464 manufacturer's instructions. Faithful replication/amplification of the library was confirmed by 465
Illumina sequencing. For lentiviral production, 4x10 6 HEK 293T cells cultured in DMEM 466 (Invitrogen), 10% FCS, L-glutamine and Penicillin-Streptomycin were seeded onto 10 cm poly-lysine 467 coated plates. The following reagents were prepared in OptiMEM per plate: 10 µg CRISPR plasmid 468 library, 10 µg VSVG-pcDNA3 (Addgene:#8454), 10 µg pCMV-dR8.2 (Addgene:#8455) and 30 µl 469 of Lipofectamine 2000 (ThermoFisher Scientific), and incubated with cells for 5-6 hours at 37°C in 470 a 5% CO2 incubator. Medium was changed to DMEM with Forskolin (5 µM/ml) and viral supernatant 471 was collected after 48 hours and 64 hours. Cell debris was removed by centrifugation at 1200 rpm 472
for 15 minutes at 4°C, and the supernatants were filtered with 0.45 µM filter. To concentrate the virus 473 supernatant, it was combined with 4xPEG solution (320ml of 50% PEG 6000, 40 ml of 5 M NaCl, 474 20 ml of 1 M HEPES, adjust pH to 7.4 and add ddH20 until 500 ml). The virus/PEG mixture was 475 incubated for 4 hours at 4°C, centrifuged at 2600g for 30 minutes at 4°C, and the supernatant 476 aspirated; the process was repeated twice. The viral titre (multiplicity of infection) was assayed by 477 determining the percentage of cells with viral integration after transduction by flow analysing BFP-478 positive cells and confirmed by qPCR (for BFP). 479 480
For the CRISPR screen we first generated SGET ESC that carried constitutive expression of Cas9 by 481 introducing a CAG-Cas9-pA cassette into SGET cells via piggybac-mediated transposition. Clones 482
were subsequently picked and screened to identify a single-copy integration of Cas9, and to confirm 483 functional capacity to direct high-efficiency gRNA-directed DNA indels using a GFP reporter. To 484 introduce the CRISPR library, a total of 5x10 7 SGET-Cas9 ESC were transduced with lentiviral 485 library using a multiplicity of infection (MOI) of 0.3, with biological replicates performed on 486 independent occasions. Transduced SGET ESC were maintained on fibronectin-coated T175 flasks 487 in N2B27, 2i/LIF and 1% KSR, with 8ng/µl of polybrene added during lentiviral infection. Medium 488 was changed 24 hours later and cells were selected with puromycin (1.2µg/ml) for 5 days. High 489 numbers of transduced ESC were passaged every 2-3 days at low ratio to ensure the complexity of 490 the gRNA library was maintained. ESC pellets were taken at day 12 for analysis and EpiLC were 491 induced on day 12 post-lentiviral transduction, from which PGCLC were subsequently induced. following cycling conditions were used: 95°C for 2 minutes, then between 21-26 cycles of (98°C for 506 20 seconds, 62°C for 20 seconds and 72°C for 20 seconds) followed by 72°C for 1 minute and hold 507 at 4°C. The number of cycles was optimised for the point at which PCR products can be first 508 visualised on an agarose gel. The PCR reaction was subsequently purified with AMPure® XP beads 509 (Beckman Coulter) using double size selection to remove primer dimers and genomic DNA. Briefly, 510 0.55x of AMPure beads were added to PCR reaction (1x) and incubated for 5 minutes at room 511 temperature. The supernatant was collected; the beads contained the unwanted larger fragments and 512 were discarded. An additional 0.3x of AMPure beads was subsequently added to the supernatant (1x) 513
and incubated for 5 minutes at room temperature. The supernatant was removed and beads washed 514 twice with 200!l of 80% EtOH, air dried for 5 minutes and DNA was eluted from AMPure beads 515 with EDTA-low TE buffer. The concentration of adaptor ligated gRNA amplicons was measured 516
with the Qubit DNA Assay kit (ThermoFisher Scientific) and the fragment distribution determined 517
with an Agilent D1000 ScreenTape System (Agilent Technologies). Libraries were subsequently 518 multiplexed and sequenced with an Illumina HiSeq 1500 using single-end 50bp reads. As the 519 sequences for all samples were identical up to the gRNA region, these types of low complexity 520 libraries can produce low quality data. To counteract this, forward staggered primers were introduced 521 at equal ratios during PCR amplification, generating offset reads. In addition, libraries were 522 sequenced with 4 dark cycles and low density (70%) clustering. 523 524
Gene editing in ESC cell lines 525
Targeted knockout ESC lines were generated using CRISPR genome editing by either deleting a 526 critical exon to generate a frame-shifted null-allele or via inducing frame-shifting null indels into 527 early coding exonic sequences. In brief, 20nt gRNAs encoding complementary sequences to the 528 region/gene to be targeted were cloned into px459 (v2.0) (Addgene:#62988) using the Bbs1 sites and 529 transfected into SGET ESC with lipofectamine 2000, according to the manufacturers guidelines. A 530 table of the gene targeting gRNAs and the editing strategy is shown below. Transfection of ESC was 531 selected for with 1.2 ug/ml puromycin for 48 hours, and ESC were subsequently passaged into 6-well 532 plates at low density (1,000-5,000 ESC per well). One week later colonies were picked and expanded 533 before undergoing genotyping by amplicon sizing and sanger sequencing to determine the precise 534 mutant sequence at each allele using the tracking of indels by decomposition tool (https://tide.nki.nl). 535
Multiple mutant lines were catalogued and validated before use in functional assays, where WT 536 and/or heterozygous control clones derived from the same targeting process were utilised. For 537 doxycycline inducible expression, Zfp296, Nr5a2 or Prdm14 cDNA was cloned into a custom 538
PiggyBac vector downstream of a doxycycline-responsive promoter, and transfected into SGET ESC 539 in conjunction with the reverse transactivator (TET-3G). Genomic integration was selected for with 540 250ug/ml neomycin. 541 542
Flow cytometry 543
For fluorescence-activated cell sorting (FACS), cultured cells or embryoids were dissociated into 544 single cells with TryLE, and suspended in phosphate buffered saline (PBS) with 0.5% BSA or 3% 545 FBS. Filtered cell suspensions were subsequently sorted using a Sony SH800Z or a MoFlow high-546
speed cell sorter (Beckman Coulter) or analysed with BD LSRFortessa X-20 (BD Biosciences). For 547 exit from pluripotency analyses, cells were sorted/analysed based on absence or presence of Stella-548 eGFP expression, whilst maintaining Esg1-tdTomato activitaion (SG+/-ET+). For PGCLC, cells 549
were sorted/analysed based on Stella-eGFP re-activation coupled with low Esg1-tdTomato. The 550 threshold(s) levels for sorting was set and normalised based on expression levels in pre-optimised 551 SGET ESC. A negative population of ESCs without any fluorescence was used to set absolute 552 thresholds. Forward and side scatters were used to gate for the cell population and doublets. For each 553 sort the maximum number of cells was collected, whilst for analysis at least 10,000 cell datapoints 554 was captured to achieve a representative sample. 555 556
RNA-seq and Gene Expression 557
For EDTA-low TE (Agilent) and sheared into ~230bp in length using S220 Focused-Ultrasonicator 567 (Covaris) using settings: duty factor 10%, cycle burst 200, intensity 5, temp at 4°C and treatment time 568
of 5 minutes per sample. A high Sensitivity D1000 ScreenTape assay (Agilent) was used to assess 569 the efficiency of library fragmentation. Fragmented ds-cDNA was concentrated with Qiagen Reaction 570
Clean Up kit (MiniElute) and 1µg of the fragmented ds-cDNA used as input for the library preparation 571 using Encore Rapid DR Multiplex Library System (Nugen). This kit ligated the adaptors to repaired-572 end ds-cDNA without amplification, which eliminated biases introduced during PCR amplification. 573
The KAPA Library Quantification Kit (Kapa bioscience) was used to quantify the concentration of 574 each adaptor-ligated libraries prior to multiplexing. The ESC, EpiLC, PGCLC and soma cell RNA 575 sequencing libraries were generated in parallel for each replicate, and the biological replicates were 576 generated on independent occasions. Samples were multiplexed and sequenced with Illumina 577
HiSeq1500, single-end 50bp read length with a minimum depth of approximately 15 million reads 578 per sample. 579 580
For RNA-seq of Nr5a2 -/-, Zfp296 -/and matched WT control cell lines, 100 ng of total RNA from 581 triplicate biological independent experiments was used as inputs for the NEBNext Ultra RNA library 582
Prep Kit for Illumina® (NEB), with the library generated as per manufacturer's instructions. During 583 the final PCR amplification stage, 15 cycles of amplifications were performed to generate the adaptor 584 ligated, fragmented cDNA for sequencing. Samples were assessed using the High Sensitivity D1000 585
ScreenTape assay (Agilent) to ensure the library did not contain primer-dimer contamination after 586 last round of AMPure beads cleaning. The Qubit dsDNA HS assay kit (ThermoFisher Scientific) and 587
the NEBNext Library Quant Kit for Illumina® was used to accurately quantify the concentration of 588 each library preparation. Samples were multiplexed with 12 indexes per lane and a total of 2 lanes of 589 sequencing on Illumina HiSeq4000, single-end 50bp with an average depth of approximately 20 590 million reads per sample. 591 592
DNA methylation 593
Global DNA methylation levels were determined using the LUminometric Methylation Analysis 594 (LUMA) method 46 and bisulfite pyrosequencing. Briefly, genomic DNA was isolated from purified 595 PGCLC using the DNeasy Blood & Tissue kit (Qiagen) and treated with RNase. 50-100ng of DNA 596 was digested with MspI/EcoRI and HpaII/EcoRI (NEB) and the subsequent methylation-sensitive 597 overhangs were quantified by Pyrosequencing (PyroMark Q24 Advance) with the dispensation order: 598
GTGTGTCACACAGTGTGT. Global CpG methylation levels were determined from relative 599 peak heights at position(s) 7, 8, 13 and 14 using the formula: 600
[(2*(p7*p13))/(p8+p14)] HpaII /[(2*(p7*p13))/(p8+p14)] MspI . CpG methylation at LINE1 loci was 601 determined by bisulfite pyrosequening using the EpiTect bisulfite kit (Qiagen). PCR amplification 602
and assay design were performed as previously described.
604
Bioinformatics 605
For RNA-seq, expression reads were quality-trimmed using TrimGalore to remove adapters, and 606 aligned to the mouse reference genome (GRCm38/mm10) using TopHat2 guided by ENSEMBL gene 607 models. Mapped reads were imported into SeqMonk analysis software and quantitated using the 608 RNA-seq quantitation pipeline. Differentially expressed genes (DEG) were identified using the 609
DESeq2 statistical package with significance thresholds set as p<0.05, filtering for a fold-change 610 (FC) >2 and mean RPKM expression >1 in at least one normalised sample. Analysis of gene ontology 611 enrichment was performed using DEG datasets in the DAVID bioinformatics resource v6.7 612 (https://david.ncifcrf.gov) and/or the REVIGO visualisation tool (http://revigo.irb.hr). Heatmaps and 613 plots were generated using custom scripts in the R statistical package. For analysis of the CRISPR 614 screen, demultiplexed gRNA sequences were extracted from Illumina reads using custom scripts to 615 account for staggered start positions. These were quantitated and statistically analysed using Model-616 based Analysis of Genome-wide CRISPR-Cas9 Knockout (MAGeCK) v.0.5.2 software in python 47 . 617
Library sequences were trimmed to exclude the bottom 1% of reads from the initial library, which 618 primarily corresponded to zero-count gRNAs. MAGeCK analysis was performed using a 'total' 619 normalisation method to compare gRNA counts with the preceding cell population during ESC-620
EpiLC-PGCLC transition (or with the vector library in the case of ESC), taking genes with p<0.01 621 for negative-or positive-enrichment in independent replicate screens as candidates. 622
623
Oligos 624 625
qRT-PCR 626
Target gene
Forward primer (5'-3') Reverse primer (5'-3') Ap2y 
